🟢 Cardio Diagnostics Holdings is trading 6.1% up in pre-market with no clear company-specific catalyst found

Cardio Diagnostics Holdings is trading at $2.08, up 6.11%, with the reason for the pre-market gain remaining uncertain.

• No clear October 5 company-specific announcement surfaced; the latest surfaced filing was a Form 4 dated October 2, not an identified new catalyst.
• The price compares with the October 2 close of $1.96.
• Broader market futures were modestly lower, so market-wide risk sentiment does not clearly explain the gain. The supplied price context is the basis for the pre-market quote.